Bringing down the host: enteropathogenic and enterohaemorrhagic E scherichia coli effector‐mediated subversion of host innate immune pathways
Author(s) -
Santos Andrew S.,
Finlay B. Brett
Publication year - 2015
Publication title -
cellular microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.542
H-Index - 138
eISSN - 1462-5822
pISSN - 1462-5814
DOI - 10.1111/cmi.12412
Subject(s) - biology , effector , innate immune system , immune system , microbiology and biotechnology , type three secretion system , secretion , virulence , host (biology) , enteropathogenic escherichia coli , immunology , gene , genetics , biochemistry
Summary Enteric bacterial pathogens commonly use a type III secretion system ( T 3 SS ) to successfully infect intestinal epithelial cells and survive and proliferate in the host. Enteropathogenic and enterohaemorrhagic E scherichia coli ( EPEC ; EHEC ) colonize the human intestinal mucosa, form characteristic histological lesions on the infected epithelium and require the T 3 SS for full virulence. T 3 SS effectors injected into host cells subvert cellular pathways to execute a variety of functions within infected host cells. The EPEC and EHEC effectors that subvert innate immune pathways – specifically those involved in phagocytosis, host cell survival, apoptotic cell death and inflammatory signalling – are all required to cause disease. These processes are reviewed within, with a focus on recent work that has provided insights into the functions and host cell targets of these effectors.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom